Dong‐Wook Kim

20.2k citations
361 papers · 11.3k indexed · 4 hit papers · h-index 45
Topics
Chronic Myeloid Leukemia Treatments (212 papers)Chronic Lymphocytic Leukemia Research (158 papers)Acute Lymphoblastic Leukemia research (74 papers)

In The Last Decade

Dong‐Wook Kim

348 papers receiving 11.0k citations

Hit Papers

Nilotinib versus Imatinib for Newly Diagnosed Chronic Mye...201020262015202020102011201220172505007501000

Peers

Dong‐Wook Kim
Comparison fields: 5 of 150
  • Hematology 8.4k
  • Genetics 6.4k
  • Rheumatology 4.0k
  • Molecular Biology 1.8k
  • Oncology 1.6k
Replace Bin Peng with:
Bin Peng China
Surapol Issaragrisil Thailand
Bruce L. Zuraw United States
Jodie L. Babitt United States
Steven R. Lentz United States
Josef S Smolen Austria
Yaddanapudi Ravindranath United States
Kunihiro Yamaoka Japan
Carole Beaumont France
Ardeshir Ghavamzadeh Iran
Dong‐Wook Kim relative to Bin Peng China Bin Peng's profile →
Citations per field
00.5×1.5×2.4×
Bin Peng · 1×
Citations per year

Countries citing papers authored by Dong‐Wook Kim

Since Specialization
Citations

This map shows the geographic impact of Dong‐Wook Kim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dong‐Wook Kim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dong‐Wook Kim more than expected).

Fields of papers citing papers by Dong‐Wook Kim

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dong‐Wook Kim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dong‐Wook Kim. The network helps show where Dong‐Wook Kim may publish in the future.

Co-authorship network of co-authors of Dong‐Wook Kim

This figure shows the co-authorship network connecting the top 25 collaborators of Dong‐Wook Kim. A scholar is included among the top collaborators of Dong‐Wook Kim based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dong‐Wook Kim. Dong‐Wook Kim is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 2
3 4
4 9
5 43
6 26
7 20
8 84
9 3
10 15
11 26
12 1
13 1
14 1
15 43
16 80
17 236
18 127
19
Comparison of steady-state imatinib (IM) trough levels, clinical response, and safety between Caucasian and Asian patients with chronic myeloid leukemia in chronic phase (CML-CP) treated with 400mg and 800mg daily doses of IM in the tyrosine kinase inhibi
3
20 371

About Dong‐Wook Kim

Dong‐Wook Kim is a scholar working on Hematology, Genetics and Rheumatology, having authored 361 papers that have together received 11.3k indexed citations. Recurring topics across this work include Chronic Myeloid Leukemia Treatments (212 papers), Chronic Lymphocytic Leukemia Research (158 papers) and Acute Lymphoblastic Leukemia research (74 papers). The work is most often cited by research in Hematology (8.4k citations), Genetics (6.4k citations) and Rheumatology (4.0k citations). Dong‐Wook Kim has collaborated with scholars based in South Korea, United States and Germany. Frequent co-authors include Andreas Hochhaus, Hagop M. Kantarjian, Jörge E. Cortes, Timothy P. Hughes, Giuseppe Saglio, Ricardo Pasqüini, Carlo Gambacorti‐Passerini, Tim H. Brümmendorf, Susan Branford and Michele Baccarani. Their work appears in journals such as Nature, New England Journal of Medicine and Cell.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026